Roy Planalp
| Roy Planalp | |
| Known for | Research on curcumin and iron-chelating anti-cancer compounds |
|---|---|
| Alma mater | Massachusetts Institute of Technology, University of California |
Roy Planalp is an American chemist and professor in the Department of Chemistry at the University of New Hampshire.[1] His published work includes studies on curcumin and on iron-chelating compounds such as tachpyridine.[2]
Education
Planalp received an S.B. in chemistry from the Massachusetts Institute of Technology in 1979.[1] He received a Ph.D. in chemistry from the University of California in 1983.[1]
Career
Planalp served as an assistant professor in the Department of Chemistry at the University of New Hampshire from 1987 to 1993.[1] He holds the rank of professor of chemistry at the University of New Hampshire as of 2025.[1]
Research
According to Semantic Scholar, Planalp has authored 47 papers that have collectively been cited 2,936 times, giving him an h-index of 19.[2] His most-cited paper, a 2008 review on curcumin published in Cellular and Molecular Life Sciences, has been cited 1,845 times.[2] Other frequently cited work examines iron chelation by curcumin and by the compound tachpyridine, including studies of tachpyridine-mediated apoptosis, caspase activation, and cell-cycle arrest.[2] Earlier work covered the synthesis of chelating ligands, including derivatives of cis,cis-1,3,5-triaminocyclohexane and a pentaacetic acid analogue of diethylenetriaminepentaacetic acid, as well as cobalt(II) Schiff-base complexes.[2]
Selected publications
- Curcumin: From ancient medicine to current clinical trials (2008), Cellular and Molecular Life Sciences[2]
- Iron chelation in the biological activity of curcumin (2006), Free Radical Biology & Medicine[2]
- Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis (2002), Journal of Biological Chemistry[2]
- Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation (2005), Blood[2]
- Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator (2004), Biochemical Pharmacology[2]
- p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator (2001), Carcinogenesis[2]
- Novel iron complexes and chelators based on cis,cis-1,3,5-triaminocyclohexane: iron-mediated ligand oxidation and biochemical properties (1998), JBIC Journal of Biological Inorganic Chemistry[2]
- Syntheses, solubilities and oxygen absorption properties of new cobalt(II) Schiff-base complexes (1998)[2]
- An improved synthesis of cis,cis-1,3,5-triaminocyclohexane. Synthesis of novel hexadentate ligand derivatives for the preparation of gallium radiopharmaceuticals (1996)[2]
- Preparation of the Novel Chelating Agent N-(2-Aminoethyl)-trans-1,2-diaminocyclohexane-N,N',N-pentaacetic Acid (H5CyDTPA), a Preorganized Analogue of Diethylenetriaminepentaacetic Acid (H5DTPA), and the Structures of Bi(III)(CyDTPA)2- and Bi(III)(H2DTPA) Complexes (1996)[2]